Blue Jet Healthcare Limited (BLUEJET.BO)

INR 686.85

(9.48%)

Net Debt Summary of Blue Jet Healthcare Limited

  • Blue Jet Healthcare Limited's latest annual net debt in 2023 was -830.93 Million INR , down -34.03% from previous year.
  • Blue Jet Healthcare Limited's latest quarterly net debt in 2024 Q1 was 3.2 Billion INR , up 485.34% from previous quarter.
  • Blue Jet Healthcare Limited reported annual net debt of -619.98 Million INR in 2022, down -6.79% from previous year.
  • Blue Jet Healthcare Limited reported annual net debt of -580.56 Million INR in 2021, down -510.34% from previous year.
  • Blue Jet Healthcare Limited reported quarterly net debt of 3.2 Billion INR for 2024 Q1, up 485.34% from previous quarter.
  • Blue Jet Healthcare Limited reported quarterly net debt of -697.03 Million INR for 2023 Q2, down -8.68% from previous quarter.

Annual Net Debt Chart of Blue Jet Healthcare Limited (2023 - 2019)

Historical Annual Net Debt of Blue Jet Healthcare Limited (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -830.93 Million INR -34.03%
2022 -619.98 Million INR -6.79%
2021 -580.56 Million INR -510.34%
2020 -95.12 Million INR -114.09%
2019 674.93 Million INR 0.0%

Peer Net Debt Comparison of Blue Jet Healthcare Limited

Name Net Debt Net Debt Difference
Alfavision Overseas (India) Limited 1.35 Billion INR 161.333%
Biocon Limited 140.18 Billion INR 100.593%
Concord Biotech Limited -372.86 Million INR -122.848%
Dishman Carbogen Amcis Limited 18.99 Billion INR 104.375%
FERMENTA BIOTECH LIMITED 1.1 Billion INR 175.237%
GENOMIC VALLEY BIOTECH LIMITED -60.73 Thousand INR -1368046.345%
Lyka Labs Limited 527.01 Million INR 257.668%
Panacea Biotec Limited -1.18 Billion INR 29.873%
SAMSRITA LABS LIMITED 21.98 Million INR 3878.796%
Servoteach Industries Limited 5016.00 INR 16565690.132%
SMS Lifesciences India Limited 992.31 Million INR 183.737%
Supriya Lifescience Limited -694.68 Million INR -19.613%
Syngene International Limited -83 Million INR -901.12%
TAKE Solutions Limited 361.37 Million INR 329.939%
Titan Biotech Limited 54.62 Million INR 1621.07%
Transgene Biotek Limited 139.93 Million INR 693.806%
Vanta Bioscience Limited 607.93 Million INR 236.682%